Intrinsic Value of S&P & Nasdaq Contact Us

Aurora Spine Corporation ASAPF OTC

Other OTC • Healthcare • Medical - Devices • CA • USD

SharesGrow Score
33/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aurora Spine Corporation (ASAPF) generated $343.18K in operating cash flow for quarter ending 2025-09-30. After capital expenditures of $203.5K, free cash flow was $139.69K.

Free cash flow margin was 3.2% of revenue. Cash conversion ratio was -2.42x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (14/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was -2.42x suggests some earnings are non-cash items

Overall SharesGrow Score: 31/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
33/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
14/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
10/100
→ Income
Aurora Spine Corporation Cash Flow History
Metric TTM Q3 FY2025 Q2 FY2025 Q1 FY2025 Q4 FY2024
Operating Cash Flow $557.28K$343.18K$200.02K$-162.35K$176.43K
Capital Expenditure $-443.18K$-203.5K$-53.59K$-191.93K$5.84K
Free Cash Flow $114.1K$139.69K$146.42K$-354.28K$182.27K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message